Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters

Fig. 1

Effect of ezetimibe on the plasma profile of the LDLR−/− hamsters fed a high-fat diet (n = 5). a, ezetimibe lowers plasma TC of the LDLR−/− hamsters; b, ezetimibe lowers plasma TG of the LDLR−/− hamsters; c, TC profiles in different lipoprotein fractions after ÄKTA-FPLC separation; d, TG profiles in different lipoprotein fractions after ÄKTA-FPLC separation. Data are expressed as mean ± SD. **p < 0.01 vs model group

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X